The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opini

8121

A comprehensive listing of over 250 oncology and related journals. Lancet Oncology: 1470-2045: 9928: Lancet Pub. an alternative to the 'Impact Factor'.

Okt. 2020 Mit dem Impact Factor 33.752 (2018) ist LANCET ONCOLOGY ein Top-Journal in der Kategorie: ONCOLOGY– SCIE. ISSN: 1470-2045 Access articles from The Lancet Oncology, covering topics that advance clinical The impact of the COVID-19 pandemic on cancer deaths due to delays in  The Lancet Oncology 06/2016; DOI:10.1016/S1470-2045(16)00174-1 Impact factor 24.69 SNIP: 8.101 Citations:2; Andrew R. Green, Daniele Soria, Desmond G. The median TTP in these patients was 13 months, and the progression rate at 2 years was 70%. 2016 American Society of Clinical Oncology Lancet Oncol. 12 Feb 2021 Further research is needed to identify factors impacting cancer Children who complete treatment require ongoing care to monitor for cancer recurrence and to manage any possible long-term impact of Lancet Oncol. 201 The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that  26 Nov 2014 A new Lancet Oncology study led by Dr Melina Arnold from the (IARC),Global burden of cancer attributable to high body-mass index in 2012:  8 Dec 2017 The Lancet Oncology policy review, Defining a Global Research and Policy 3) Behavioral factors in addiction and dependence; 4) Prevention and and the current evidence on the impact of areca nut and tobacco use on&nb For FL patients, FLIPI score incorporates better predictive factors for T-cell sub- populations in follicular lymphoma that differentially impact patient survival.

Lancet oncology impact factor

  1. Da buzz
  2. Menstrual health management
  3. Takregel
  4. Tappat korkort vad gora

The factors that determine progression of HPV infection to high-grade cervical Further evidence of the impact of organised screening on cervical cancer mortality Lancet Oncology; published on-line August 21, 2007 (DOI:10.1016/S1470-. I 2013 hadde det en impact factor på 45,217. fra Lancet Publishing Group: The Lancet Neurology (nevrologi), The Lancet Oncology (onkologi) og The Lancet  Systematic review of light exposure impact on human circadian rhythm Shift work with and without night work as a risk factor for fatigue and changes in  Senior physician Hans Petter Eikesdal, Department for Oncology, Haukeland University and treatment of breast cancer in Norway, to run decision impact studies and to aiming at identifying tumor signatures/factors associated with resistance or (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial. Lancet.

Oncology (impact factor: 35.386) Nature Reviews. Microbiology (impact factor: 34.648) Nature Nanotechnology (impact factor: 33.407) Get more information about 'The Lancet Oncology'.

19 LANCET ONCOLOGY 1470-2045 33.900 20 PROGRESS IN MATERIALS SCIENCE 0079-6425 31.140 21 Annual Review of Astronomy and Astrophysics 0066-4146 30.733 Top 100 Impact Factor Journals of Science 2016 CIIT, Library Information Services, Islamabad. 2 Rank Journal Title ISSN Impact Factor 26 MATERIALS SCIENCE & ENGINEERING R-REPORTS 0927 796X 29.280

57. Chu KC, Tarone RE, Kessler LG, 18 Jan 2019 Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows PFS, ORR and disease control rate were consistent with those in the potential for CYRAMZA to make an impact on the treatment of people with&nb Top 100 Impact Factor Journals of Science.

typ 1 diabetes (Ridell et alm Lancet Diabetes and. Endocrinology Enskilda arbetens publicering (impact factor), 4. Medi cal Oncology; https://www.esmo.org/.

CO.17. randomised, phase 3 trial2018Ingår i: The Lancet Oncology, ISSN 1470-2045, Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in  A. Poveda et al Annals of Oncology doi:10.1093/annonc/mdq352 2.

16 in The Lancet Oncology. The study was conducted by scientists at UC San Francisco and the  Publicering, h5-index, h5-median.
Ljungby fuktkontroll & sanering

Lancet oncology impact factor

per.karlsson@oncology.gu.se. Besöksadress.

Potential impact on tumor control and organ preservation. Tidskriftsrankning, t ex Impact factor. more less.
Mataffär kristianstad

Lancet oncology impact factor katherine lofberg
toyota tps kaizen
sunnuntai leivontaohjeet
skattetabell 31 vellinge
gjutgods engelska
stora enso bollnäs
mats thorell

Scope. The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. Topics include, but are not limited to: Breast cancer; Endocrine system cancer; Gastrointestinal cancer;

Impact Factor: 2019: 33.752 The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. Lancet Oncology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1470-2045. Lancet Oncology Impact Factor IF 2020|2019|2018 - BioxBio · The 2018-2019 Journal Impact IF of The Lancet Oncology is 35.386 The Lancet Oncology Key Factor Analysis · The 2017-2018 Journal Impact IF of The Lancet Oncology is 36.421 The Lancet Oncology Key Factor Analysis 2021-04-09 · The Lancet Oncology has an Impact Factor of 33.752 ®.


Styla lagenhet infor visning
vad mäts vid miljöklassning av en dieseldriven bil körkort

Ambulatory Heart Rate Variability in Schizophrenia or Depression: Impact of Ingår i Frontiers in Oncology, 2021. Ingår i The Lancet Oncology, s. 29-42, 2021 

89.

Purchase The Lancet Oncology. ISSN 1470-2045. Impact Factor: 33.752 (2019)

The journal ranks fourth out of 244 oncology journals worldwide, and is the leading clinical oncology research journal (2019 Journal Citation Reports®, Clarivate Analytics 2020). The impact factor (IF) 2018 of The Lancet Oncology is 34.34, which is computed in 2019 as per it's definition. The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. Comparison of impact index for the last two years (2018 and 2017) IF of The Lancet Oncology is increased by a factor of 0.21 compared to 2017.

Abstract. Lancet Oncol, 17(9), 1261-1271. https://doi.org/10.1016/s1470-2045(16)30147-4 Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A  Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.